Case report:: Kinetics of Epstein-Barr virus load in a bone marrow transplant patient with no sign of lymphoproliferative disease

被引:18
作者
Biasolo, MA
Calistri, A
Cesaro, S
Gentile, G
Mengoli, C
Palù, G
机构
[1] Univ Padua, Dipartimento Istol Microbiol & Biotecnol Med, Padua, Italy
[2] Univ Padua, Clin Oncoematol Pediat, Padua, Italy
[3] Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy
关键词
EBV load growth rate; post-transplant lymphoproliferation;
D O I
10.1002/jmv.10285
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The kinetics of Epstein-Barr virus (EBV) load was measured in peripheral blood mononuclear cells of a severely immunocompromised allogeneic bone marrow recipient child, in conditions not associated with lymphoproliferative disease. The viral doubling time was 46.4 hr. The study permitted monitoring EBV clearance from blood, when the anti-rejection therapy was interrupted. Likely, this is the first accurate kinetic assessment of EBV load increasing phase in a clinical context marked by the absence of an overt post-transplant lymphoproliferative disease. According to these data gamma-herpesviruses behave like beta-herpesviruses in being capable of rapid growth.
引用
收藏
页码:220 / 224
页数:5
相关论文
共 12 条
[1]   Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas [J].
Brink, AATP ;
Dukers, DF ;
vandenBrule, AJC ;
Oudejans, JJ ;
Middeldorp, JM ;
Meijer, CJLM ;
Jiwa, M .
JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (11) :911-918
[2]  
Chadburn A, 1997, SEMIN DIAGN PATHOL, V14, P15
[3]  
de Kok JB, 1998, CLIN CHEM, V44, P2201
[4]   Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation [J].
Emery, VC ;
Sabin, CA ;
Cope, AV ;
Gor, D ;
Hassan-Walker, AF ;
Griffiths, PD .
LANCET, 2000, 355 (9220) :2032-2036
[5]   Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders [J].
Limaye, AP ;
Huang, ML ;
Atienza, EE ;
Ferrenberg, JM ;
Corey, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :1113-1116
[6]  
Nalesnik M A, 1997, Ann Transplant, V2, P33
[7]   Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy [J].
Neumann, AU ;
Lam, NP ;
Dahari, H ;
Gretch, DR ;
Wiley, TE ;
Layden, TJ ;
Perelson, AS .
SCIENCE, 1998, 282 (5386) :103-107
[8]  
OUDEJANS JJ, 1995, AM J PATHOL, V147, P923
[9]   Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients [J].
Preiksaitis, JK ;
Keay, S .
CLINICAL INFECTIOUS DISEASES, 2001, 33 :S38-S46
[10]   Toward standardization of Epstein-Barr virus DNA load monitoring: Unfractionated whole blood as preferred clinical specimen [J].
Stevens, SJC ;
Pronk, I ;
Middeldorp, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1211-1216